Share: Facebook Twitter LinkedIn
Activity Provided By:

Primary Care Education Consortium

Long-term Treatment of Gout: New Opportunities for Improved Outcomes

Access Activity

Overview / Abstract:

LEARNING OBJECTIVES
• Make a presumptive diagnosis of gout based on history and physical
examination
• Individualize and modify urate-lowering therapy based on best evidence to achieve treatment goals
TARGET AUDIENCE
Family physicians and clinicians who wish to gain increased knowledge and greater competency regarding primary care management of the long-term treatment of gout.
Gout is an independent predictor of premature death and is associated with a high frequency of comorbidities, without many with a prevalence 2 to 3 times higher than among people gout: hypertension, chronic kidney disease (CKD), obesity, type 2 diabetes, nephrolithiasis, cardiac disease (including coronary artery disease, heart failure, and atrial fibrillation), dyslipidemia, stroke, peripheral arterial disease, and sleep apnea.
Gout is a common disorder that is associated with significant patient morbidity, as well as with comorbidities such as CKD, diabetes, and various cardiovascular disorders. Diagnosis is often based on history and physical examination, with confirmation by joint aspiration when necessary. Lifestyle management generally provides modest reduction of the sUA level. Several urate-lowering medications have been approved for chronic therapy. Allopurinol is typically used as first-line therapy. When combination therapy is required to achieve the target sUA level, the choice is generally based on patient specific factors, physician and patient choice, and cost.

Expiration

Jul 31, 2019

Discipline(s)

Physician CME

Format

Journal

Credits / Hours

1

Accreditation

AACME, AMA PRA Category 1

Presenters / Authors / Faculty

Paul P. Doghramji, MD, FAAFP, Family Physician, Collegeville
Family Practice, Medical Director of Health Services, Ursinus
College, Collegeville, Pennsylvania

Sponsors / Supporters / Grant Providers

This article is supported by an educational
grant from Ironwood Pharmaceuticals, Inc.

Keywords / Search Terms

Primary Care Education Consortium gout, hypertension, chronic kidney disease (CKD), obesity, type 2 diabetes, nephrolithiasis, cardiac disease, coronary artery disease, heart failure, atrial fibrillation, dyslipidemia, stroke, peripheral arterial disease, sleep apnea. Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map